Aktis Oncology, Inc.AKTSNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank50
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

Percentile
P50
Within normal range
vs 2Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2024$37.16M+25.9%
2023$29.51M-77.1%
2022$128.60M-